These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15047157

  • 1. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine.
    Song Y, Kesuma D, Wang J, Deng Y, Duan J, Wang JH, Qi RZ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):128-32. PubMed ID: 15047157
    [Abstract] [Full Text] [Related]

  • 2. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
    Zaharevitz DW, Gussio R, Leost M, Senderowicz AM, Lahusen T, Kunick C, Meijer L, Sausville EA.
    Cancer Res; 1999 Jun 01; 59(11):2566-9. PubMed ID: 10363974
    [Abstract] [Full Text] [Related]

  • 3. High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design.
    Schulze-Gahmen U, De Bondt HL, Kim SH.
    J Med Chem; 1996 Nov 08; 39(23):4540-6. PubMed ID: 8917641
    [Abstract] [Full Text] [Related]

  • 4. 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
    Lin R, Lu Y, Wetter SK, Connolly PJ, Turchi IJ, Murray WV, Emanuel SL, Gruninger RH, Fuentes-Pesquera AR, Adams M, Pandey N, Moreno-Mazza S, Middleton SA, Jolliffe LK.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2221-4. PubMed ID: 15837297
    [Abstract] [Full Text] [Related]

  • 5. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM.
    Curr Opin Drug Discov Devel; 2001 Sep 02; 4(5):623-34. PubMed ID: 12825457
    [Abstract] [Full Text] [Related]

  • 6. DNA binding properties of 9-substituted harmine derivatives.
    Cao R, Peng W, Chen H, Ma Y, Liu X, Hou X, Guan H, Xu A.
    Biochem Biophys Res Commun; 2005 Dec 23; 338(3):1557-63. PubMed ID: 16288723
    [Abstract] [Full Text] [Related]

  • 7. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK.
    Biochem Pharmacol; 2008 Jun 15; 75(12):2289-300. PubMed ID: 18468578
    [Abstract] [Full Text] [Related]

  • 8. Cyclin-dependent kinase inhibitors.
    Fischer PM, Endicott J, Meijer L.
    Prog Cell Cycle Res; 2003 Jun 15; 5():235-48. PubMed ID: 14593718
    [Abstract] [Full Text] [Related]

  • 9. Cyclins and related kinases in cancer cells.
    Malumbres M.
    J BUON; 2007 Sep 15; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [Abstract] [Full Text] [Related]

  • 10. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
    Deep G, Oberlies NH, Kroll DJ, Agarwal R.
    Carcinogenesis; 2007 Jul 15; 28(7):1533-42. PubMed ID: 17389612
    [Abstract] [Full Text] [Related]

  • 11. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R.
    Oncogene; 2006 Feb 16; 25(7):1053-69. PubMed ID: 16205633
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases.
    Misra RN, Xiao HY, Williams DK, Kim KS, Lu S, Keller KA, Mulheron JG, Batorsky R, Tokarski JS, Sack JS, Kimball SD, Lee FY, Webster KR.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2973-7. PubMed ID: 15125971
    [Abstract] [Full Text] [Related]

  • 13. Small molecules as inhibitors of cyclin-dependent kinases.
    Huwe A, Mazitschek R, Giannis A.
    Angew Chem Int Ed Engl; 2003 May 16; 42(19):2122-38. PubMed ID: 12761741
    [Abstract] [Full Text] [Related]

  • 14. Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death.
    Lefèvre K, Clarke PG, Danthe EE, Castagné V.
    J Comp Neurol; 2002 May 20; 447(1):72-81. PubMed ID: 11967896
    [Abstract] [Full Text] [Related]

  • 15. Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.
    McInnes C, Wang S, Anderson S, O'Boyle J, Jackson W, Kontopidis G, Meades C, Mezna M, Thomas M, Wood G, Lane DP, Fischer PM.
    Chem Biol; 2004 Apr 20; 11(4):525-34. PubMed ID: 15123247
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata.
    Lim H, Kim MK, Lim Y, Cho YH, Lee CH.
    Cancer Lett; 2006 Feb 20; 233(1):89-97. PubMed ID: 16473670
    [Abstract] [Full Text] [Related]

  • 17. Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.
    Caridha D, Kathcart AK, Jirage D, Waters NC.
    Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3863-7. PubMed ID: 20627564
    [Abstract] [Full Text] [Related]

  • 18. Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity.
    Simone M, Erba E, Damia G, Vikhanskaya F, Di Francesco AM, Riccardi R, Bailly C, Cuevas C, Fernandez Sousa-Faro JM, D'Incalci M.
    Eur J Cancer; 2005 Oct 01; 41(15):2366-77. PubMed ID: 16181779
    [Abstract] [Full Text] [Related]

  • 19. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E.
    ChemMedChem; 2009 Jan 01; 4(1):19-24. PubMed ID: 19039815
    [Abstract] [Full Text] [Related]

  • 20. Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro.
    Nakamura K, Yokoyama N, Igarashi I.
    Parasitology; 2007 Sep 01; 134(Pt 10):1347-53. PubMed ID: 17634158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.